How to Navigate Ecosystem Connect NEWDistinguished Investigators Global Conferences RLT Education RLT Components Sponsors Trial Stats
Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma
Description:
To evaluate the relationship between 18F-FSPG uptake in HCC lesions, ctDNA in blood and clinical response to Y90 radioembolization therapy in patients with hepatocellular carcinoma (HCC) by SOC imaging.
Sponsor:
MD Anderson Cancer Center
Contacts:
Simone Krebs, MDsskrebs@mdanderson.org
(713) 563-6726
Government Study Link:
NCT07116486 - Click here to see study onClinicalTrials.gov
18F-FSPG
Isotope(s):
Target(s):
- Cystine/glutamate antiporter
